ELITE PHARMACEUTICALS INC /NV/ 8-K

What Happened
Elite Pharmaceuticals, Inc. (ELTP) filed a Form 8-K on June 23, 2026 (Items 2.02 and 7.01) to report its results of operations and financial condition for the fiscal year ended March 31, 2026. The company issued a press release (Exhibit 99.1) and announced a conference call to discuss the fiscal year results on Tuesday, June 30, 2026 at 11:30 AM EDT.

Key Details

• Conference call: June 30, 2026 at 11:30 AM EDT; conference number: 98840.
• Dial-in numbers: 1-800-346-7359 (domestic) and 1-973-528-0008 (international).
• Question submission: general questions to [email protected] by 5:00 PM EDT on Friday, June 26, 2026; financial questions by 7:00 PM EDT on Monday, June 29, 2026.
• Press release attached as Exhibit 99.1 to the 8-K; the filing notes the disclosure is furnished (Item 9.01) and not “filed” for purposes of Section 18 of the Exchange Act or incorporated by reference elsewhere.

Why It Matters
This filing signals that Elite will disclose its fiscal 2026 financial results and provide management commentary via the scheduled earnings call — important for investors tracking earnings, revenue, cash flow, and outlook. The call and attached press release are the primary sources for the company’s reported results; investors who want to ask questions or hear management’s discussion should note the call time, dial-in details, and the deadlines for submitting questions.